{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:22Z","timestamp":1793332342577,"version":"4.5.0"},"reference-count":68,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1080\/14740338.2024.2305707","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T07:27:41Z","timestamp":1707722861000},"page":"161-175","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program"],"prefix":"10.1080","volume":"23","author":[{"given":"Daniel A.","family":"Salmon","sequence":"first","affiliation":[{"name":"Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"},{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"},{"name":"Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Chen","sequence":"additional","affiliation":[{"name":"Brighton Collaboration, A program of the Task Force for Global Health, Decatur, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Black","sequence":"additional","affiliation":[{"name":"Global Vaccine Data Network, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Sharfstein","sequence":"additional","affiliation":[{"name":"Department of Health, Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,2,11]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.023"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30130-4"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.0396"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14828"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0878"},{"key":"e_1_3_5_8_1","unstructured":"World_Health_Organization. Ten threats to global health in 2019. Available from: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2020.02254"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.034"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01693-2"},{"key":"e_1_3_5_12_1","unstructured":"Kahn KH Jatlaoui TC Skoff TH et al. Flu Tdap and COVID-19 vaccination coverage among pregnant women \u2013 United States April 2022. 2023. Available from: https:\/\/www.cdc.gov\/flu\/fluvaxview\/pregnant-women-apr2022.htm"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7245a2"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/154.11.1006"},{"key":"e_1_3_5_15_1","unstructured":"CDC. Vaccine Safety Datalink Publications. 2023. Available from: https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/vsd\/publications.html"},{"key":"e_1_3_5_16_1","unstructured":"Institute of Medicine (U.S.) Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines Howson CP Howe CJ et al. Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Washington (DC): National Academy Press; 1991."},{"key":"e_1_3_5_17_1","unstructured":"Stratton KR Howe CJ Johnston RB et al. Adverse events associated with childhood vaccines : evidence bearing on causality. Washington (DC): National Academy Press; 1994."},{"key":"e_1_3_5_18_1","unstructured":"Institute of Medicine (U.S.) Committee to Review Adverse Effects of Vaccines. Stratton KR. Adverse effects of vaccines : evidence and causality. Washington (DC): National Academies Press; 2012."},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piw084"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13370"},{"key":"e_1_3_5_21_1","unstructured":"Institute_of_Medicine. Evaluation of poliomyelitis vaccines. Washington (DC): National Academy Press; 1977."},{"key":"e_1_3_5_22_1","unstructured":"Stratton KR Almario DA McCormick MC et al. Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders. Washington (DC): National Academies Press; 2002."},{"key":"e_1_3_5_23_1","unstructured":"Stratton KR Gable A McCormick MC et al. Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders. Washington (DC): National Academy Press; 2001. (The Compass series)."},{"key":"e_1_3_5_24_1","unstructured":"Stratton KR Institute of Medicine (U.S.) Board on Health Promotion and Disease Prevention. Institute of Medicine (U.S.) Immunization Safety Review Committee. Immunization safety review : measles-mumps-rubella vaccine and autism. Washington (DC): National Academy Press; 2001. (The Compass series)."},{"key":"e_1_3_5_25_1","unstructured":"Stratton KR Institute of Medicine (U.S.) Immunization Safety Review Committee. Immunization safety review : influenza vaccines and neurological complications. Washington (DC): National Academies Press; 2004."},{"key":"e_1_3_5_26_1","unstructured":"Stratton KR Institute of Medicine (U.S.) Immunization Safety Review Committee. Immunization safety review : vaccinations and sudden unexpected death in infancy. Washington (DC): National Academies Press; 2003."},{"key":"e_1_3_5_27_1","unstructured":"Stratton KR Wilson CB McCormick MC et al. Immunization safety review: multiple immunizations and immune dysfunction. Washington (DC): National Academy Press; 2002. (The Compass series)."},{"key":"e_1_3_5_28_1","unstructured":"Institute of Medicine (U.S.) Board on Health Promotion and Disease Prevention. Institute of Medicine (U.S.). Immunization Safety Review Committee. Immunization safety review : vaccines and autism. Washington (DC): National Academies Press; 2004."},{"key":"e_1_3_5_29_1","unstructured":"An Evaluation of Poliomyelitis Vaccine Policy Options. DC (WA): The National Academies Press; 1988. English."},{"key":"e_1_3_5_30_1","unstructured":"CDC. Vaccine against 2009 H1N1 influenza virus 2009-2010 [cited 2023 Nov 10]. Available from: https:\/\/www.cdc.gov\/h1n1flu\/vaccination\/public\/vaccination_qa_pub.htm"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61877-8"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.003"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.014"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62189-8"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.008"},{"key":"e_1_3_5_37_1","unstructured":"Services UDoHa H. Federal plans to monitor immunization safety for the pandemic H1N1 influenza vaccination program. DC (WA): US Department of Health and Human Services; 2009."},{"key":"e_1_3_5_38_1","unstructured":"FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine [internet]. 2020. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19"},{"key":"e_1_3_5_39_1","unstructured":"Shimabukuro T. COVID-19 Vaccine safety updates 2021. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-06\/03-COVID-Shimabukuro-508.pdf"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7008e3"},{"key":"e_1_3_5_41_1","unstructured":"Global Vaccine Data Network. Available from: https:\/\/www.globalvaccinedatanetwork.org"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7114e1"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7027e2"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.11.031"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1967"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.12.971"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2116999"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2002690"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110737"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.69677"},{"issue":"7","key":"e_1_3_5_52_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/pin.13234","article-title":"Myocarditis after COVID-19 mRNA vaccination in three young adult males: significance of biopsy in vaccine-associated myocarditis","volume":"72","author":"Amemiya K","year":"2022","unstructured":"Amemiya K, Kobayashi T, Kataoka Y, et al. Myocarditis after COVID-19 mRNA vaccination in three young adult males: significance of biopsy in vaccine-associated myocarditis. Pathol Int. 2022 Jul;72(7):385\u2013387.","journal-title":"Pathol Int"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2022.2066522"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01630-0"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003476"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.0583"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0101"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab989"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.7326\/M21-3700"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1038043"},{"key":"e_1_3_5_62_1","doi-asserted-by":"crossref","first-page":"e068665","DOI":"10.1136\/bmj-2021-068665","article-title":"SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study","volume":"375","author":"Husby A","year":"2021","unstructured":"Husby A, Hansen JV, Fosbol E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 2021 Dec 16;375:e068665.","journal-title":"BMJ"},{"key":"e_1_3_5_63_1","unstructured":"Klein NP ACIP presentation: myocarditis analyses in the vaccine safety datalink: rapid cycle analyses and \u201chead-to-head\u201d product comparisons 2022. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2022-02-04\/10-COVID-Klein-508.pdf"},{"key":"e_1_3_5_64_1","unstructured":"Oliver S. ACIP presentation: updates to the evidence to recommendation framework: pfizer-BioNTech COVID-19 booster in children aged 5-11 years 2022. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2022-05-19\/06-COVID-Oliver-508.pdf"},{"key":"e_1_3_5_65_1","unstructured":"FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review [internet]. 2021. Available from: https:\/\/www.cdc.gov\/media\/releases\/2021\/fda-cdc-lift-vaccine-use.html"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7017e4"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7103a4"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8879"},{"issue":"3","key":"e_1_3_5_69_1","first-page":"681","article-title":"Balancing consumer and industry interests in public health: the National Vaccine Injury Compensation Program and its influence during the last two decades","volume":"111","author":"Rutkow L","year":"2007","unstructured":"Rutkow L, Maggy B, Zablotsky J, et al. Balancing consumer and industry interests in public health: the National Vaccine Injury Compensation Program and its influence during the last two decades. Penn State Law Rev. 2007;111(3):681\u2013738.","journal-title":"Penn State Law Rev"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1086\/322577"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac407"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2305707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T07:28:30Z","timestamp":1707722910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2305707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1080\/14740338.2024.2305707"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2305707","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}